Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Beverly L. Falcón | Researchclopedia

Back to researchers

Beverly L. Falcón

Eli Lilly (United States)

137

Works

2,120

Citations

18

h-index

20

i10-index

Research Topics

Angiogenesis and VEGF in Cancer Cancer, Hypoxia, and Metabolism Lipid metabolism and disorders

Affiliations

Amgen (United States)2010–2010

Exelixis (United States)2011–2011

Eli Lilly (United States)2012–2026

University of California, San Francisco2007–2023

Indianapolis Zoo2021–2021

Top Works

Tirzepatide as Compared with Semaglutide for the Treatment of Obesity

Louis J. Aronne,Deborah B. Horn,et al.

2025297 citations

Cancer, Lipids, and Metabolism

Pancreatic and Hepatic Oncology Research

VEGF and c-Met Blockade Amplify Angiogenesis Inhibition in Pancreatic Islet Cancer

Weon‐Kyoo You,Barbara Sennino,et al.

2011259 citations

Complementary Actions of Inhibitors of Angiopoietin-2 and VEGF on Tumor Angiogenesis and Growth

Hiroya Hashizume,Beverly L. Falcón,et al.

2010247 citations

Contrasting Actions of Selective Inhibitors of Angiopoietin-1 and Angiopoietin-2 on the Normalization of Tumor Blood Vessels

Beverly L. Falcón,Hiroya Hashizume,et al.

2009218 citations

Sequential Loss of Tumor Vessel Pericytes and Endothelial Cells after Inhibition of Platelet-Derived Growth Factor B by Selective Aptamer AX102

Barbara Sennino,Beverly L. Falcón,et al.

2007153 citations

Antagonist antibodies to vascular endothelial growth factor receptor 2 (VEGFR-2) as anti-angiogenic agents

Beverly L. Falcón,Sudhakar Chintharlapalli,et al.

2016151 citations

Context-Dependent Role of Angiopoietin-1 Inhibition in the Suppression of Angiogenesis and Tumor Growth: Implications for AMG 386, an Angiopoietin-1/2–Neutralizing Peptibody

Angela Coxon,James Bready,et al.

2010148 citations

Adjuvant capecitabine plus bevacizumab versus capecitabine alone in patients with colorectal cancer (QUASAR 2): an open-label, randomised phase 3 trial

Rachel Kerr,Sharon Love,et al.

2016148 citations

Reduced VEGF Production, Angiogenesis, and Vascular Regrowth Contribute to the Antitumor Properties of Dual mTORC1/mTORC2 Inhibitors

Beverly L. Falcón,Sharon Barr,et al.

201191 citations